vs
Side-by-side financial comparison of DENNY'S Corp (DENN) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
DENNY'S Corp is the larger business by last-quarter revenue ($113.2M vs $75.5M, roughly 1.5× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 1.3%). DENNY'S Corp produced more free cash flow last quarter ($16.0M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -0.9%).
Denny's is an American table service diner-style restaurant chain. It operates over 1,400 restaurants in the United States, Canada, México, Puerto Rico, and several other international locations.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
DENN vs PBYI — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $113.2M | $75.5M |
| Net Profit | $632.0K | — |
| Gross Margin | — | 69.3% |
| Operating Margin | 9.2% | 22.7% |
| Net Margin | 0.6% | — |
| Revenue YoY | 1.3% | 27.7% |
| Net Profit YoY | -90.3% | — |
| EPS (diluted) | $0.01 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $75.5M | ||
| Q3 25 | $113.2M | $54.5M | ||
| Q2 25 | $117.7M | $52.4M | ||
| Q1 25 | $111.6M | $46.0M | ||
| Q4 24 | $114.7M | $59.1M | ||
| Q3 24 | $111.8M | $80.5M | ||
| Q2 24 | $115.9M | $47.1M | ||
| Q1 24 | $110.0M | $43.8M |
| Q4 25 | — | — | ||
| Q3 25 | $632.0K | $8.8M | ||
| Q2 25 | $2.5M | $5.9M | ||
| Q1 25 | $326.0K | $3.0M | ||
| Q4 24 | $6.8M | — | ||
| Q3 24 | $6.5M | $20.3M | ||
| Q2 24 | $3.6M | $-4.5M | ||
| Q1 24 | $4.7M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
| Q4 25 | — | 22.7% | ||
| Q3 25 | 9.2% | 17.6% | ||
| Q2 25 | 7.3% | 12.7% | ||
| Q1 25 | 4.7% | 8.7% | ||
| Q4 24 | 12.6% | 22.6% | ||
| Q3 24 | 10.5% | 27.4% | ||
| Q2 24 | 7.9% | -4.6% | ||
| Q1 24 | 9.1% | -5.3% |
| Q4 25 | — | — | ||
| Q3 25 | 0.6% | 16.2% | ||
| Q2 25 | 2.1% | 11.2% | ||
| Q1 25 | 0.3% | 6.5% | ||
| Q4 24 | 5.9% | — | ||
| Q3 24 | 5.8% | 25.2% | ||
| Q2 24 | 3.1% | -9.6% | ||
| Q1 24 | 4.3% | -11.0% |
| Q4 25 | — | $0.26 | ||
| Q3 25 | $0.01 | $0.17 | ||
| Q2 25 | $0.05 | $0.12 | ||
| Q1 25 | $0.01 | $0.06 | ||
| Q4 24 | $0.13 | $0.40 | ||
| Q3 24 | $0.12 | $0.41 | ||
| Q2 24 | $0.07 | $-0.09 | ||
| Q1 24 | $0.09 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $-32.7M | $130.3M |
| Total Assets | $502.9M | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | $1.1M | $93.2M | ||
| Q4 24 | $100.0K | $101.0M | ||
| Q3 24 | $2.9M | $96.7M | ||
| Q2 24 | $2.8M | $96.8M | ||
| Q1 24 | $2.8M | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | $270.6M | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | — | $130.3M | ||
| Q3 25 | $-32.7M | $115.3M | ||
| Q2 25 | $-34.6M | $104.7M | ||
| Q1 25 | $-36.4M | $97.1M | ||
| Q4 24 | $-34.0M | $92.1M | ||
| Q3 24 | $-54.5M | $71.1M | ||
| Q2 24 | $-53.2M | $48.5M | ||
| Q1 24 | $-55.7M | $51.0M |
| Q4 25 | — | $216.3M | ||
| Q3 25 | $502.9M | $202.9M | ||
| Q2 25 | $491.1M | $194.9M | ||
| Q1 25 | $488.1M | $196.2M | ||
| Q4 24 | $496.3M | $213.3M | ||
| Q3 24 | $461.6M | $220.7M | ||
| Q2 24 | $459.9M | $205.0M | ||
| Q1 24 | $460.4M | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.0M | $14.4M |
| Free Cash FlowOCF − Capex | $16.0M | $14.4M |
| FCF MarginFCF / Revenue | 14.1% | 19.1% |
| Capex IntensityCapex / Revenue | 0.0% | 0.0% |
| Cash ConversionOCF / Net Profit | 25.28× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $14.4M | ||
| Q3 25 | $16.0M | $9.7M | ||
| Q2 25 | $9.4M | $14.1M | ||
| Q1 25 | $5.0M | $3.6M | ||
| Q4 24 | $8.5M | $15.6M | ||
| Q3 24 | $6.6M | $11.0M | ||
| Q2 24 | $14.2M | $1.0M | ||
| Q1 24 | $215.0K | $11.2M |
| Q4 25 | — | $14.4M | ||
| Q3 25 | $16.0M | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
| Q4 25 | — | 19.1% | ||
| Q3 25 | 14.1% | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | 25.28× | 1.10× | ||
| Q2 25 | 3.79× | 2.41× | ||
| Q1 25 | 15.38× | 1.21× | ||
| Q4 24 | 1.26× | — | ||
| Q3 24 | 1.01× | 0.54× | ||
| Q2 24 | 3.97× | — | ||
| Q1 24 | 0.05× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DENN
| Franchisor Owned Outlet | $57.4M | 51% |
| Royalty | $27.7M | 25% |
| Advertising | $18.6M | 16% |
| Occupancy | $7.7M | 7% |
| Initial And Other Fees | $1.7M | 1% |
PBYI
Segment breakdown not available.
